Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-hypofractionated Adjuvant Radiotherapy After Breast Conserving Surgery in Breast Cancer Patients

NCT05586256 is registered in ClinicalTrials.gov with University Of Perugia as lead sponsor.

NCT NCT05586256
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05586256 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-hypofractionated Adjuvant Radiotherapy After Breast Conserving Surgery in Breast Cancer Patients
Lead sponsor
University Of Perugia
Phase
Observational
Overall status
Unknown status
Start date
July 21, 2021
Completion date
July 21, 2026
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

female breast cancer